Patient-Reported Anxiety Impacts Utilization of Injectable On-demand Treatment of Hereditary Angioedema Attacks

Radojicic C

American College of Allergy, Asthma & Immunology 2024 (ACAAI)

Correlation of Time to Treatment with Attack Duration in the Sebetralstat KONFIDENT Phase 3 Trial

Craig T

American College of Allergy, Asthma & Immunology 2024 (ACAAI)

On-demand Treatment of Laryngeal Hereditary Angioedema Attacks with Sebetralstat: Pooled Analysis from KONFIDENT and KONFIDENT-S

Aygören-Pürsün E

American College of Allergy, Asthma & Immunology 2024 (ACAAI)

Substantial Reduction of Hereditary Angioedema Attack Symptom Burden in the Sebetralstat Phase 3 KONFIDENT Trial

Lumry W

American College of Allergy, Asthma & Immunology 2024 (ACAAI)

Indirect treatment comparison of oral sebetralstat and intravenous rhC1-INH as on-demand treatments for hereditary angioedema

Li HH

American College of Allergy, Asthma & Immunology 2024 (ACAAI)

Global Frequency and Diagnosis of Hereditary Angioedema with Normal C1INH: A Real World ACARE Survey

Magerl M

ACARE Global Angioedema Forum 2024 (GAF)

Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks

Zanichelli A

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Delayed Treatment of Hereditary Angioedema Attacks on Quality of Life and Ability to Work

Yong P

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Hereditary Angioedema Attacks on Quality of Life and Ability to Work Among UK Patients Receiving Long-term Prophylaxis or On-demand Treatment Only

Savic S

ACARE Global Angioedema Forum 2024 (GAF)

The Hereditary Angioedema (HAE) Attack Journey: A Conceptual Model of Patient Anxiety and On-Demand Treatment Burden During an HAE Attack

Jones D

ACARE Global Angioedema Forum 2024 (GAF)